EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma

BACKGROUND: Targeted therapy with anti-human epidermal growth factor receptor-2 (HER2) monoclonal antibody in patients with HER2 overexpressed esophagogastric adenocarcinoma (EGA) improves survival; however, the effect is transient due to the development of resistance. Some studies suggest that cMet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastrointest Oncol
Autors principals: Chan, Ellie, Alkhasawneh, Ahmad, Duckworth, Lizette Vila, Aijaz, Tabish, Toro, Tania Zuluaga, Lu, Xiaomin, Hughes, Steven J., Collinsworth, Amy, George, Thomas J.
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5177589/
https://ncbi.nlm.nih.gov/pubmed/28078108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.06.09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars